Polysubstituted 4,6-bis(hetero)arylpyrimidines as dual inhibitors of nitric oxide and prostaglandin E2 production.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nitric oxide

• Publication date

  2017-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.niox.2017.05.001PMID 28483702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dual inhibition of nitric oxide and prostaglandin E2 production by polysubstituted 2-aminopyrimidines.

  2016cited by this paper
• Variation of the aryl substituent on the piperazine ring within the 4-(piperazin-1-yl)-2,6-di(pyrrolidin-1-yl)pyrimidine scaffold unveils potent, non-competitive inhibitors of the inflammatory caspases.

  2016cited by this paper
• Human Toll-like Receptor (TLR) 8-Specific Agonistic Activity in Substituted Pyrimidine-2,4-diamines.

  2016cited by this paper
• Synthesis, anticancer and molecular docking studies of benzofuran derivatives

  2015cited by this paper
• Synthesis and structure–activity relationship studies of polysubstituted pyrimidines as inhibitors of immune-activated nitric oxide production

  2015cited by this paper
• 5-Substituted 2-amino-4,6-dihydroxypyrimidines and 2-amino-4,6-dichloropyrimidines: synthesis and inhibitory effects on immune-activated nitric oxide production

  2014cited by this paper
• Synthesis and 3D‐QSAR Analysis of 2‐Chloroquinoline Derivatives as H37RV MTB Inhibitors

  2013cited by this paper
• New imidazo[1,2-a]pyridines carrying active pharmacophores: synthesis and anticonvulsant studies.

  2013cited by this paper
• Pseudo-cyclization through intramolecular hydrogen bond enables discovery of pyridine substituted pyrimidines as new Mer kinase inhibitors.

  2013cited by this paper
• Synthesis and biological evaluation of pyrimidine-based dual inhibitors of human epidermal growth factor receptor 1 (HER-1) and HER-2 tyrosine kinases.

  2012cited by this paper
• Role of nitric oxide-synthase and cyclooxygenase/lipooxygenase systems in development of experimental ulcerative colitis.

  2011cited by this paper
• Synthesis and SAR of 6-chloro-4-fluoroalkylamino-2-heteroaryl-5-(substituted)phenylpyrimidines as anti-cancer agents.

  2009cited by this paper
• Synthesis and antimycobacterial activity of 5-formylaminopyrimidines; analogs of antibacterial purines.

  2009cited by this paper
• Synthesis, analgesic and anti-inflammatory activities evaluation of some bi-, tri- and tetracyclic condensed pyrimidines.

  2009cited by this paper
• Synthesis and Biological Evaluation of Some Novel Polysubstituted Pyrimidine Derivatives as Potential Antimicrobial and Anticancer Agents

  2009cited by this paper
• A novel 5-[1,3,4-oxadiazol-2-yl]-N-aryl-4,6-pyrimidine diamine having dual EGFR/HER2 kinase activity: design, synthesis, and biological activity.

  2008cited by this paper
• Influence of simultaneous inhibition of cyclooxygenase-2 and inducible nitric oxide synthase in experimental colitis in rats

  2007cited by this paper
• Synthesis and biological evaluation of some 5-ethoxycarbonyl-6-isopropylamino-4-(substitutedphenyl)aminopyrimidines as potent analgesic and anti-inflammatory agents.

  2007cited by this paper
• One pot synthesis of pyrimidine and bispyrimidine derivatives and their evaluation for anti-inflammatory and analgesic activities.

  2007cited by this paper
• Biological and medicinal significance of pyrimidines

  2006cited by this paper
• Synthesis of 2,4,6-trisubstituted pyrimidine and triazine heterocycles as antileishmanial agents.

  2006cited by this paper
• Pyrimidine as Constituent of Natural Biologically Active Compounds

  2005cited by this paper
• Synthesis, anti-inflammatory and analgesic activities evaluation of some mono, bi and tricyclic pyrimidine derivatives.

  2005cited by this paper
• Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.

  2002cited by this paper
• Ethenesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists.

  2001cited by this paper
• COX-2 and iNOS, good targets for chemoprevention of colon cancer.

  2000cited by this paper
• A new stereospecific cross-coupling by the palladium-catalyzed reaction of 1-alkenylboranes with 1-alkenyl or 1-alkynyl halides

  1980cited by this paper
• A general, selective, and facile method for ketone synthesis from acid chlorides and organotin compounds catalyzed by palladium

  1978cited by this paper
• Triphenylpropylpiperazine derivatives as new potent analgetic substances.

  1972cited by this paper

• The 2-aminopyrimidine ring as a new scaffold for potent MRP1 inhibitors.

  2025cites this paper
• Molecular properties prediction, anticancer and anti-inflammatory activities of some pyrimido[1,2-b]pyridazin-2-one derivatives

  2023cites this paper
• Polysubstituted Pyrimidines as Potent Inhibitors of Prostaglandin E2 Production: Increasing Aqueous Solubility

  2021cites this paper
• Polysubstituted Pyrimidines as mPGES-1 Inhibitors: Discovery of Potent Inhibitors of PGE2 Production with a Strong Anti-inflammatory Effects in Carrageenan-Induced Rat Paw Edema.

  2020cites this paper
• Development of Scalable Synthesis of 5-Butyl-4-(4-methoxyphenyl)-6-phenylpyrimidin-2-amine (WQE-134), a Dual Inhibitor of Nitric Oxide and Prostaglandin E2 Production

  2020cites this paper
• Influence of the C-5 substitution in polysubstituted pyrimidines on inhibition of prostaglandin E2 production.

  2018cites this paper